Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Places Clinical Hold On Phase 3 Trial Of Novel Anticoagulant
FDA Places Clinical Hold On Phase 3 Trial Of Novel Anticoagulant
FDA Places Clinical Hold On Phase 3 Trial Of Novel Anticoagulant
Submitted by
admin
on July 10, 2014 - 3:42pm
Source:
Forbes
News Tags:
FDA
Regado Biosciences
anticoagulants
Revolixys
Headline:
FDA Places Clinical Hold On Phase 3 Trial Of Novel Anticoagulant
Do Not Allow Advertisers to Use My Personal information
